CRMP5-IgG–Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy

Authors:

Abstract
This case report describes CRMP5-IgG–associated paraneoplastic myelopathy with PD-L1 inhibitor therapy in a woman in her 60s.

This publication has 3 references indexed in Scilit: